© Copyright Nostre Net
Auto-injectors
fall under an important segment of medical devices designed to drug dose
delivery in a calculated manner. These injectors are used for delivering
life-saving drugs. They are extremely effective in tackling severe allergic
reactions. Auto-injectors are one of the several inventions focused toward
bettering care giving. The continuous advances in medical technology has led to
development of effective auto-injectors. Latest versions of the device are more
user-friendly and cost-efficient. These injectors are intended for
self-administration by patients. They do not require special training for
homecare givers to administer drugs. Such factors make the devices extremely
important and practical. Market Research Future (MRFR) projects that the global
auto-injectors
market companies will reach a valuation of more than USD 2 Bn by the year
2022. To reach this valuation, the market is projected to exhibit a compound annual
growth rate (CAGR) of 17.2% from 2016 to 2022.
The advent of
auto-injectors has helped in tackling the challenges faced in
self-administration. These injectors are far more superior than conventional
needle-based drug delivery devices. The technology is quite simple, as
spring-loaded system is used in for functionality. Most auto-injectors that are
currently available have plastic body, which help in deterring unnecessary
contamination. Rising incidences of allergic
diseases associated with anaphylaxis and other allergies globally is expected
to influence the global auto-injectors market.
Get Sample
Report @https://www.marketresearchfuture.com/sample_request/2046
Global Auto-Injectors
Market: Competitive Landscape
UNILIFE
CORPORATION, Enbrel, Owen Mumford Ltd., Amedra Pharmaceuticals LLC,
Scandinavian Health Ltd., and kaleo, Inc. are among the global auto-injectors
market.
Global Auto-Injectors Market: Segmental Overview
The segmental analysis of
the global auto-injectors market has been conducted on the basis of product
type, application, and suppliers.
Based on product type, the
market has been segmented into reusable, disposable and others. Based on
application, the market has been segmented into rheumatoid arthritis,
anaphylaxis, multiple sclerosis, allergies and others. Based on supplier, the
market has been segmented into retailers, pharmacy, online retailers and others.
Global Auto-Injectors Market: Regional Segmentation
Key regions mentioned in
MRFR’s report include South America, North America, Europe, Asia Pacific (APAC)
and the Middle East & Africa (MEA). In terms of revenue, North America
holds the top spot in the global auto-injectors market. In addition, the
auto-injectors market in North America is projected to reach the size of USD
0.9 Bn towards the end of assessment period. Faster uptake of advanced
technologies and presence of a robust healthcare systems in the U.S. is
supporting the market growth in the region. North America is expected to remain
a highly attractive market for auto-injectors during the forecast period.
Europe holds the second spot in the global auto-injectors market in terms of
revenue. Factors such as high healthcare expenditure and strong government
support are propelling the market in Europe. Meanwhile, the APAC auto-injectors
market is expected to exhibit a register the highest CAGR during the forecast
period.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/auto-injector-market-2046
The Plastic Surgery And Integumentary System Procedures
Market is predicted to grow at a healthy CAGR between 2016-2022, states the
latest Market Research Future (MRFR) report. Plastic surgery, simply put, is a
medical process to restore, correct, or alter skin on different parts of the
body. It is generally performed as a cosmetic or reconstructive procedure. On
the other hand, the integumentary system, simply put, is an organ framework
that includes skin as well as its extremities, which protects the body against
various forms of damages. It is mostly done for skin cancer, herpes, rabies,
athlete’s foot, rubella, psoriasis, acne, rash, sunburn, and infection.
Various factors are propelling the plastic surgery and
integumentary system procedures market growth. These factors as stated by the
latest Market Research Future report, include growing demand for procedures
especially cryosurgery, chemobrasion, and laser therapy, the influence of
social media, increasing media exposure, increasing rates of obese people,
advancements in technology in surgeries, increasing demand for retaining beauty
and youth, and increasing geriatric population.
On the flip side, the soaring cost of these procedures may
deter plastic
surgery and integumentary system procedures market share over the forecast
period.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/1982
Key Players
Notable players profiled in the plastic surgery and
integumentary system procedures market report include Scivision Biotech Inc,
Integra Lifesciences, Sanofi, Valeant Pharmaceuticals, Allergan, Merz Pharma,
Galderma, Lumenis, Alma Lasers, Cynosure Inc., and Allergen Inc.
Market Segmentation
The MRFR report offers a wide segmental analysis of the on
the basis of plastic surgery and integumentary system procedures market based
on end user, application, operating area, and procedure.
Based on the procedure, the plastic surgery and
integumentary system procedures market is segmented into skin tests, culture
and sensitivity, incisional biopsy, excisional biopsy, and prefilled syringe
biopsy.
Based on the operating area, the plastic surgery and
integumentary system procedures market is segmented into skin, nose, breast,
subcutaneous tissue, and eyelids.
Based on application, the plastic surgery and integumentary
system procedures market is segmented into augmentation, skin cancer, athlete’s
foot, infection, autograft, allograft, and skin grafts.
Based on the end user, the plastic surgery and integumentary
system procedures market is segmented into research institutes, research
laboratories, and hospitals and clinics.
Regional Analysis
By region, the plastic surgery and integumentary system
procedures market report covers the latest trends and growth opportunities
across Europe, North America, the Asia Pacific, and the Middle East and Africa.
Of these, North America will dominate the market over the forecast period. Factors
pushing the growth of the plastic surgery and integumentary system procedures
market in the region include growing demand for cosmetic procedures, highest
expenditure by government sectors on the healthcare sector, consumers changing
lifestyle, growing senior population, growing awareness about surgical
procedures, and early adoption of new medical technologies.
The plastic surgery and integumentary system procedures
market in Europe is projected to have the second-largest share during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include increasing rates
of surgeries owing to changing lifestyles, increasing research and development
activities, and increasing support and funding from the government to the
healthcare sector.
The plastic surgery and integumentary system procedures
market in the APAC region is projected to have a favorable growth during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include the availability
of high-quality services, budding medical tourism, high access to technology,
and improving healthcare infrastructure.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/plastic-surgery-integumentary-system-market-1982
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
The
surge in cancer diagnoses globally is estimated to fuel the progress of the Cancer
Diagnostics Market. The market's report is efficiently analyzed as per MRFR,
which provides outlooks for the global markets. By 2025, the market is on track
to earn USD 163,000 Million by 2025 with an 8.9% CAGR.
The
advancement in diagnostic markers and science has led to the development of the
cancer diagnostics market in the
forthcoming period. The improvement in reimbursement policies is estimated to
support the expansion of the cancer
diagnostics market share in the impending period.
Get
Sample Report @https://www.marketresearchfuture.com/sample_request/1962
Competitive Analysis
The market is projected to witness a period of
turbulence with the impact of the pandemic on the workforce and the economy as
a whole. The collaborative efforts of the market contenders are expected to
broaden the horizons for development in the foreseeable future. The measures
being undertaken to ensure seamless functioning of the market is estimated to
lay off in the long run. The investment towards cutting-edge technology is
anticipated to take a sharp surge with amplified funding accessibility. The
formation of strong trade relations among several regions is forecasted to have
a beneficial effect on growth. The focus on the client's needs is estimated to
be more important than before as changes in living standards can have a notable
bearing on the popularity of certain market trends. The contenders in the
market are likely to see aggressive competition in the coming years. The
reimagined market structure is predicted to rely on a combination of robust
online selling capabilities and a capable supply chain.
The distinguished companies in the cancer diagnostic
market are Arquer Diagnostics Ltd, Illumina, Inc., Becton, Dickinson and
Company (BD), BioMark Diagnostics Inc., Biotheranostics, Exact Sciences
Corporation, Cancer Diagnostics, Inc., Agilent Technologies, Inc., Thermo
Fisher Scientific, Inc., GE Healthcare, QIAGEN N.V., Roche Diagnostics, Siemens
Healthcare, Abbott Laboratories, Inc., and Koninklijke Philips N.V., Inc.
Segmental Analysis
The segmental overview of the cancer diagnostics market is carried out on
the basis of type, application, end user and regions. The cancer diagnostics
market's application segment comprises breast cancer, colorectal cancer,
melanoma cancer, lung cancer, prostate cancer, and liver cancer. The cancer
diagnostics market's end user segment comprises hospitals and clinics,
diagnostic centers, and research institutes. The region segment of the cancer
diagnostics market comprises of the Americas, the Middle East, Africa, Europe,
and the Asia Pacific. The type segment of the cancer diagnostics market
comprises of biomarkers testing, biopsy, imaging testing, and in-vitro
diagnostic testing.
Regional Overview
The regional examination of the cancer
diagnostics market comprises of the Americas, the Middle East, Africa, Europe,
and the Asia Pacific. The Americas cancer diagnostics market governed the global
market due to the mounting elderly inhabitants, the firm healthcare sector, and
growing healthcare spending. The European cancer diagnostics market held the
second major part of the cancer diagnostics market. The growing awareness about
cancer, technological developments in the region, and mounting demand for
efficient handling and diagnostics for cancer is anticipated to drive the
development of the regional cancer diagnostics market. Germany directed the
largest portion in the European market for cancer diagnostics. The Asia-Pacific
cancer diagnostics market is anticipated to register the fastest development in
the cancer diagnostics market throughout the forecast period owing to the
incidence of a large patient collection and snowballing government proposals
for the growth of the healthcare sector in the region. Nations in Asia-Pacific
are implementing advanced treatment options, which in turn powers the cancer
diagnostics market growth in this region.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/cancer-diagnostics-market-1962
About US:
Market Research Future (MRFR) has
launched a new study on the global bladder cancer market. The global bladder
cancer market is expected to exhibit a robust 12.5% CAGR over the forecast
period from 2017 to 2023. The report presents a detailed review of the
historical growth trajectory of the global bladder cancer market in order to
provide reliable projections about the probable growth trajectory of the global
bladder cancer market over the forecast period.
Bladder cancer is cancer of the
urinary bladder, which is a temporary reservoir for urine as it passes out of
the body. The kidneys, where urine is produced, are connected to the urinary
bladder, which further releases urine into the ureters and out through the urethra.
Bladder cancer can be brought on by recurrent bladder infections, exposure to
radiation on a consistent basis, and consumption of tobacco in either chewed or
smoked form. The global bladder
cancer market growth is likely to be driven by the growing prevalence of
smoking around the world, as smoking tobacco is seen to be the strongest
causative agent for bladder cancer.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1899
Competitive Analysis:
Leading players in the global
bladder cancer market include AstraZeneca PLC, Celgene Corporation, F.
Hoffman-La Roche AG, Novartis International AG, Sanofi SA, Accord Healthcare,
Bedford Lab, Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline PLC, Eli Lilly
and Company, and Bristol-Myers Squibb Company.
Segmentation:
The global bladder cancer market
is segmented on the basis of type, treatment, diagnosis, end user, and
region.
On the basis of type, the global
bladder cancer market is segmented into transitional cell bladder cancer,
invasive bladder cancer, superficial bladder cancer, squamous cell bladder
cancer, adenocarcinoma, and others.
On the basis of treatment, the
global bladder cancer market is classified into chemotherapy, immunotherapy,
radiation therapy, surgery, and others. Chemotherapy is classified into Valstar
(valrubicin), Javlor (vinflunine ditartrate), Mitomycin C, Gemcitabine and
cisplatin chemotherapy (GemCis), and others.
On the basis of diagnosis, the
global bladder cancer market is classified into urine lab tests, cystoscopy,
biopsy, imaging tests, and others. The urine lab tests segment is further
classified into urinalysis, urine cytology, urine culture, and urine tumor
marker test. The imaging test segment is further divided into intravenous
pyelogram (IVP), computed tomography (CT), magnetic resonance imaging (MRI),
and bladder ultrasound.
On the basis of end user, the
global bladder cancer market is classified into hospitals, clinics, cancer care
centers, and others.
Regional Analysis:
The global bladder cancer market
is segmented into the Americas, Europe, Asia Pacific, and the Middle East and
Africa on the basis of geography.
The Americas is the leading
geographical segment of the global bladder cancer market and is likely to hold
on to the top position over the forecast period due to the increasing
prevalence of bladder cancer and the rapid development of innovative, advanced
cancer therapies. The developed healthcare sector in this region has led to the
development of targeted therapies and other innovations, which is likely to be
a major driver for the bladder cancer market in North America over the forecast
period. Considerable research efforts have also been directed at enabling early
diagnosis of bladder cancer, so that the treatment can have more efficacy.
Europe is also a major regional
player in the global bladder cancer market and is likely to remain a leading
contributor to the global bladder cancer market over the forecast period due to
the presence of a highly advanced healthcare sector, especially in Western
Europe. Asia Pacific is likely to exhibit strong growth in the bladder cancer
market over the forecast period.
Browse Full Report @ https://www.marketresearchfuture.com/reports/bladder-cancer-market-1899
Mobile health or mHealth is the practice use of mobile
devices for the purpose of health services, information, and data collection.
mHealth has emerged as a booming field due to advancements in the use of information
and communication technology (ICT), for health services and information.
mHealth applications include the use of mobile devices such as mobile phones,
tablet computers and wearable devices such as smart watches, in collecting
health data, delivery of healthcare information, real-time monitoring, and
direct provision of care via mobile telemedicine.
The mHealth
market trends is growing at an explosive pace due to the factors such as
increasing awareness of mobile technology applications, surging focus on
patient-centric healthcare deliver, technological innovations, concerns over
the rising cost of healthcare delivery, growing integration of wireless
technologies, convenience of medical devices, falling prices and growing
affordability of mobile devices and others.
The factors constraining the market are low mobile and
network coverage in developing and poorer regions of the world, lower accuracy,
poor penetration of smart devices, nascent technology in underdeveloped
economies, limited reimbursement, lack of technological awareness among the
ageing population, concerns over information security and privacy and others.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1816
The largest players in the mHealth market are Apple,
AT&T, AirStrip, Boston Scientific, CardioNet, Athena health, Sanofi,
Fitbit, Telcare, Zephyr Technology and others
A careful analysis of the factors reveals the following;
Poor network coverage and quality represent the most
critical factor restraining the market
Technological development in the mobile device and
information management systems represent the critical opportunity factor for
the market
Growing mobile device affordability and awareness are the
critical driving factors behind the market growth. According to Pew research,
78% of adults under 30 own a laptop or desktop computer, compared with 88% in
2010. Smartphone ownership, is very high at 86% of in 2015 in the age group of
18- to 29-year-olds.
The global mHealth market is projected to reach USD 21.71
billion by 2022, growing at a CAGR of 35.65% during the forecast period.
mHealth Market is segmented by devices, services, technology
and applications. The device segment is sub segmented into blood glucose
meters, BP monitors, pulse oximetry, neurological monitoring, wearable fitness
sensor device, heart rate meters and others. The services segment is sub
segmented into diagnosis, monitoring, prevention, treatment, and others. The
application segment is sub segmented into cardiovascular, respiratory,
neurological, genetic diseases and others.
Regional outlook
While mHealth grew out of industrialized nations, the field
has shifted in favour of the developing countries, stemming from the rapid rise
of mobile phone penetration in low-income nations. For example, in a study
conducted by Pew research in contrast to a median of 45% across emerging and
developing countries reported using the internet occasionally in 2013, the
number in 2015, rose to a whopping 54%. The largest growth has been reported
from large emerging economies such as Malaysia, Brazil and China. The
comparative figures in 2015 was 87% for advanced economies such as U.S. and
Canada, major Western European nations, Australia, Japan etc.
Another example can be seen in the falling divide for
smartphone ownership between developing and developed economies. Smartphone
ownership rates in emerging and developing nations climbed from a median of 21%
in 2013 to an eye watering 37% in 2015. There also is an effect of the
demographic dividend that is paying well for the market as in nearly every
country, millennials are much more likely to be internet and smartphone users
compared with those ages 35 and older. Other findings reveal that smartphone
ownership rates have skyrocketed in many countries since 2013. This includes
increases of over 25 percentage points among the economies of Turkey, Malaysia,
Chile and Brazil.
Report Details @ https://www.marketresearchfuture.com/reports/mobile-health-market-1816
Rheumatoid arthritis is a chronic inflammatory condition
that possible can distress more than just the joints. It is found that in some
individuals, the disorder also can damage a various parts of body system,
including the lungs, skin, eyes, heart and blood vessels. The global Rheumatoid
Arthritis Market is expected to grow at a healthy CAGR of ~4% during the
forecast period 2017-2022.
The major factors influencing the Rheumatoid
Arthritis Market shareinclude high number of individuals suffering
from the autoimmune disease, it has been observed that this disease is found
three times more in women than as men. The reason behind gender gap is still
unknown, but researchers say it’s something to do with the hormones. According
to Health Union, LLC is one of the common chronic disease that affects
approximately 1.3 million Americans and as much as 1% of the global population.
Big pharmaceutical companies taking steps for the development of products
related to rheumatoid arthritis is further influencing the growth of the
market. Moreover there is a huge opportunity in developing nations that is
grabbed by various market players for expanding their presence in the region.
The market is forecast to demonstrate a steady growth by 2022, surpassing its
previous growth records in terms of value with a striking CAGR during the
anticipated period 2017–2022.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1658
Global Rheumatoid Arthritis Market - Competitive Analysis
Pfizer Inc. (U.S), Eli Lilly and company (U.S),
Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (Switzerland),
Novartis AG (Switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi
(France), AstraZeneca (U.K) are some of the prominent players at the forefront
of competition in the Global Rheumatoid Arthritis Market and are profiled in
MRFR Analysis.
Characterized by the presence of several well-established
and small players, the global market of rheumatoid arthritis appears to be
highly competitive and fragmented. With well-established market in the North
America region major companies like Pfizer Inc., Eli Lilly and Company,
Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, and various
others have their home in the region and generate maximum market share. These
companies have expanded their operating unit in various other emerging regions
as well. Moreover the other small and medium scale players are generating
revenue from local market.
The market for rheumatoid arthritis is highly competitive
with companies focusing on the development of oral drug and treatment. U.S
based pharmaceutical company Pfizer is one of the leaders in the market. The
company in February 2016, announced the approval of its product XELJANZ XR (tofacitinib citrate) by the U.S.
Food and Drug Administration (FDA). The 11mg drug product has been approved for
daily once treatment of medium to severe rheumatoid arthritis. XELJANZ has been
approved in more than 45 countries across the globe for the treatment of
moderate to severe RA. The company has been involved in this market for more
than 60 years and being the leader in the market continues for the development
of the market.
Global Rheumatoid Arthritis Market - Regional Analysis
The global market is segmented into the various regions
including Americas, Europe, Asia Pacific, and the Middle East & Africa. The
Americas accounts for the largest market share of about more than ~38 market
share due to increasing patient pool visiting professionals due to rheumatoid
arthritis and favourable governmental conditions for research and development.
According to the study conducted by the Centers for Disease Control and
Prevention in March 2017 it was estimated that about 54.4 million U.S. adults
suffer from arthritis that is approximately about 25% of its population.
Arthritis is the key cause of disability, and causing pain, aching, stiffness,
and swelling of the joints. The most common type of arthritis is rheumatoid
arthritis & osteoarthritis. According to the same study it is expected that
by 2040, 78 million i.e. 26% of the U.S. adults of age 18 years or older are
anticipated to have doctor-diagnosed arthritis.
Europe is the second largest market of rheumatoid. U.K. the
fastest growing market rheumatoid arthritis in the Europe. According to the
National Rheumatoid Arthritis Society (NRAS) it is estimated that approximately
690,000 people suffer from rheumatoid arthritis across the UK. Furthermore
government taking initiates for the awareness of rheumatoid arthritis is
influencing the growth of the market.
Asia Pacific expected to be the fastest growing region. The
Asia Pacific region accounting for more 60% of the world's population has
provided a great opportunity for researchers to study the epidemiology,
pathogenesis and influencing various manufacturers for the expansion of their
unit in this region. There has been huge development for the treatment of
rheumatoid arthritis since the formation of the Asia Pacific League of
Associations for Rheumatology (APLAR) in 1963. Due to various developments in
the region there is potential growth in the region.
The Middle East & Africa holds the least share in the
rheumatoid arthritis market due to lack of awareness, less emphasis on research
and development activities, and poor medical facilities.
Browse Full Report @ https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658
About US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Scenario
The global Knee Replacement Market is presumed to experience
6.1% CAGR during the forecast period (2017-2023) owing to the increasing
geriatric population, asserts Market Research Future (MRFR). Knee replacement
is also referred to joint replacement surgery which is meant for patients suffering
from knee damage. Diseases such as post-traumatic arthritis, osteoarthritis,
and rheumatoid arthritis generally cause knee damage. Knee arthroplasty or knee
replacement is performed to replace damaged knee with artificial knee implants.
Drivers and Constraints Impacting the Market
Knee replacement is highly driven by the geriatric
population due to old age ailments such as osteoporosis, arthritis, and
diabetes. Advent of advanced technologies such as minimally invasive surgery,
presence of better implant materials, and extensive research and development
activities in the industry are considered to propel the market during the
assessment period. According to the American Joint Replacement Registry, 87 %
of the diagnosed osteoarthritis cases undergo knee replacement. With growing
prevalence of osteoarthritis, the number of knee replacement has risen. Also,
the adaptation of sedentary lifestyle has led to obese population which is
considered to foster the Knee
replacement market trends in the future.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1578
Competitive Dashboard
The major players operating the global market are DePuy
Synthes, Allegra Orthopaedics Limited, Exactech Inc., Smith and Nephew, Zimmer
Inc., Stryker, and Kinamed Inc.
Global Knee Replacement Market: Segmental Analysis
The global knee replacement market has been segmented on the
basis of material, product type, end-user, and region.
By mode of product type, the global knee replacement market
has been segmented into total knee reconstructive implants, partial knee
reconstructive implants, and revision knee reconstructive implants. Among
these, the total knee reconstructive implants are further sub-segmented into
fixed bearing implants, mobile bearing implants, medial pivot implants, and
others.
By mode of material, the global knee replacement market has
been segmented into ceramic material, metal alloy, strong plastic parts, and
others.
By mode of end-users, the global knee replacement market has
been segmented into specialty centers, hospitals and clinics, and
rehabilitation centers.
Regional Insights
Geographically, the knee replacement market spans across
regions namely, North America, Europe, Asia Pacific, and the Middle East and
Africa.
Among all the regions, the North American market is
considered to be a growing market owing to the growing geriatric population
affected by knee disorders. Also, growing awareness regarding joint treatments
are further considered to drive the market during the assessment period. For
instance, according to the American Joint Replacement Registry, more than
161,040 joint replacement procedures were performed in 2015.
Europe is presumed to be the second largest market after
North America and is estimated to hold a noticeable share. The growth is
attributed to the availability of advanced and innovative treatment facilities
coupled with growing skilled medical professionals in this region. Also, with
the growing geriatric population giving rise to patient population, the market
is considered to expand at a rapid pace.
Asia Pacific is presumed to be the fastest growing market owing
to the increasing prevalence of joint disorders such as osteoarthritis and
arthritis. Increasing awareness about health along with availability of
advanced treatment methods are likely to foster the market in this region.
Access Report @ https://www.marketresearchfuture.com/reports/knee-replacement-market-1578
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private
Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
Sports are now a days considered as a mean to maintain the health. Sports
medicines are used for the treatment of different sports injuries. North
America sports medicines and therapies market size is driven by increasing
prevalence of sports injures, introduction of sports education in schools,
adoption of sports by elderly people and increasing governmental support for
research and development of the sports medicines. Increasing health care
expenditure per person is also contributed for the growth of market. On other
had lack of skilled professionals handling pediatrics sports injuries and high
cost of treatment may hinder the growth of the market. North America sports
medicine & therapies market is expected to grow at a CAGR of 8.6 % during
forecasted period.
Geographically, North America sports
medicine & therapies market trends is dominated by US. US share 65% of
the total North America sports medicines and therapies market.
Increasing pediatrics sports injuries in US is the major reason for the
development of the market. According to the research one in every four school
injuries are serious includes dislocation, fracture and brain damage. 62 % of
sports related injuries occur during practices due to lack of safety measures.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1283
North America sports medicine & therapies market, by
area of application
The major key player for the North America sports
medicines and therapies market are Smith & Nephew plc (UK), DePuy
Synthes (US), Medtronics (UK), Zimmer (US), Arthrex, Inc. (US), Stryker
Corporation (US), Breg, Inc. (US), CONMED Corporation (US), Tornier N.V. (US),
DonJoy, Inc. (US), Mueller Sports, Inc.(US), Ottobock Healthcare GmbH
(Germany), DJO Global (US), Cramer, Inc.(US).
Some of the key strategies adopted by these players are
agreements and collaborations, mergers and acquisitions, and new product
launches. Many companies are trying to launch new product to increase their
market.
Smith & Nephew one of the global leaders in
manufacturing healthcare products that help medical professional to provide quality
and efficient healthcare headquartered in UK. This company share a major part
of North America sports medicine and therapies market. In 2017, Smith &
Nephew plc signed a distribution agreement and strategic investment with Leaf
Healthcare, Inc. and in 2016 company has acquired BST-CarGel, a first-line
cartilage repair product from Piramal Healthcare (Canada) Limited.
Medtronic is a global healthcare solutions company committed to improving the
lives of people headquartered in UK. Stratis, TriTis and ArthroPort Cannula
System are some of the major products of the company.
Stryker Corporation is a US headquartered medical
device company. Company is involved in manifracturing of different medical
devices which are used in the treatment of different injuries. Pivot
cinchlock, Iconix and Biosteon are some of the major products of the company.
In 2016, company has launched BIO Delivery System and in 2017 they has
announced their collaboration with AlloSource for the distribution of
medication use in treatment of sport injuries.
Arthrex, Inc a leading sports medicine and medical device
company headquartered in US. Arthroscopic Knotless TFCC Repair, Elbow
Arthroscopy Set Suture, FiberStick and ACL Preservation are the major products
of the company. This company share approximately 25% of total market share.
Segmentation:
North America sports medicine & therapies market is segmented on the
basis of product into helping fractures heal, surgical devices,
arthroscopy devices, orthopaedic braces. Helping fractures heal are further sub
segmented into bone graft substitutes, bone morphogenetics proteins,
viscosupplementation, PRP, bone marrow concentrate and other. Surgical devices
are sub segmented into plates, screws and other. Orthopaedic braces are sub
segmented into knee braces, foot braces and supports and other.
On the basis of area of application the market is segmented
into spine, foot and knee, hip, shoulder and elbow and other. On the basis of
procedures the market is segmented into tendinosis, tendon to bone and
cartilage repair. And on the basis of end user they are segmented into
hospitals & emergency care, trauma centers, ambulatory care and
other.
Access Report Details @ https://www.marketresearchfuture.com/reports/north-america-sports-medicine-therapies-market-1283
About US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
The diversification of healthcare facilities has been
motivated by the expansion in the market size and growing demand for medical
services. Market reports connected with healthcare industry have been offered
by Market Research Future which creates reports on other industry verticals
that intends to analyze the current market scenarios better. The market is set
to achieve revenues valued at USD 270 billion while achieving a CAGR of 12.9%
in the duration of the forecast period.
The e-health
services market trends is benefitted by the presence of a robust
information and telecommunication sector, which has led to a significant
development in the market. The current technological developments in the market
are fuelled by the widespread use of software in healthcare and the need to
reduce cost and improve efficiencies. Moreover, the market for e-health
services is expected to be encouraged by the rising implementation of e-health
software in medical facilities globally.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/1252
Competitive Analysis
The competitors functioning in the market for e-health services are Allscripts Healthcare Solutions Inc.
(U.S), GE Healthcare (U.S), Boston Scientific Corp (U.S), McKinsey & Co.
(U.S), Apple (U.S), Motion Computing Inc. (U.S), Epocrates Inc. (U.S), Telecare
Corp. (U.S), IBM Corporation (U.S), Proteus Digital Health (U.S) GE Healthcare
(U.S) and Cerner (U.S).
Segmental Analysis
The segmentation of the e-health services market is carried
out on the basis of type, region, and service.Based on type, the e-health service market comprises of segments
such as ePrescribing, Electronic Health Records (EHR), big data systems,
Telemedicine, Clinical Decision Support System (CDSS), Knowledge Management
System (KMS) and Consumer health IT.
Based on service, the market for e-health services is segmented into
clinical services, financial services, and administrative services. The end user segment of the e-health service
market comprises of clinics, hospitals, health insurance companies, and others.
The regions encompassed in the e-health services market are Europe, Asia
Pacific, Americas, and the Middle East and Africa.
Detailed Regional
Analysis
The regional analysis of the e-health services market
comprises of regions such as Europe, the Americas, Asia Pacific, Middle East,
and Africa. The North American region is the principal market for the
e-health services market which is driven by countries such as the US. The
presence of top companies and the extensive implementation of software for data
management in the market is boosting the progress of the market. The
European region is observed as the next chief region in the e-health services
market. The Asia Pacific region is showing the most rapid growth in this
e-health services market. While the e-health services market in the Middle East
and Africa is estimated to display steady growth in the duration of the
forecast period.
Access full report @ https://www.marketresearchfuture.com/reports/e-health-services-market-1252
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Demand for oxygen therapies had
been rising in the last couple of decades as numerous studies have pointed out
that patients who undergo oxygen therapy live longer and lead more active
lives. Medical
oxygen concentrators market has therefore been expanding as oxygen
concentrators have come to be increasingly used in not only hospitals and
clinics but at homes by patients who require outpatient treatments or patients
who wish to travel and continue to lead normal lives with considerable mobility
in spite of the need for continuous requirement of oxygen supply.
Oxygen concentrators are less
portable than the other options. An oxygen concentrator is a device that takes
oxygen from the room, concentrates it for therapeutic use, and removes other
naturally occurring gases. The benefits of concentrators are that they are less
expensive and don’t require filling like tanks. Portable versions are
available. However, most models are too large to be truly portable.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/7876
Competitive Landscape:
Some of the companies that are
making considerable contribution to the medical oxygen concentrators market
include Philips Healthcare, Invacare Corporation, AirSep Corporation, Drive
DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek
Medical Products, Inc., Precision Medical, Inc., GCE Group, Besco Medical
Limited, O2 Concepts, LLC, Inogen, Teijin Limited, OSI - Oxygen Solutions Inc.
Segmentation
The global medical oxygen concentrators market has been segmented into
product, technology, indication, end user, and region.
By product, the market has been segmented into portable oxygen
concentrators and stationary oxygen concentrators.
On the basis of technology, the market has been divided into the
continuous flow and pulse dose.
Based on indication, the market has been categorized into chronic
obstructive pulmonary disease, asthma, sleep apnea, and others.
By end user, the market has been classified into homecare, travel,
hospitals and clinics, and others. Home oxygen concentrators facilitate
convenience and make it easier and safer for the patient to complete their
day-to-day activities, which is supporting the dominance of the homecare
segment during the next six years.
Regional Analysis:
Geographically, the North America
held a substantial share in the medical oxygen concentrators market in 2018
which can be attributed to the presence of established home healthcare care
services, active participation of key market players, increasing incidence of
respiratory diseases, and favorable reimbursement scenario in the U.S. and
Canada.
Expanding geriatric population in
Europe coupled with rising prevalence of asthma, pulmonary hypertension, COPD,
and fibrosis, would lead the region to be the second largest value
contributor to the medical oxygen concentrators market.
Increasing healthcare
expenditure, improvement in healthcare infrastructure and expanding awareness
about need for oxygen concentrators will augment Asia-Pacific medical oxygen
concentrators market growth. The region is anticipated to register the fastest
market CAGR over 2018-2024 owing to increasing demand for portable
concentrators.
The medical oxygen concentrators
market in the Middle East & Africa would witness the modest market growth
rate from 2018 to 2024. The Middle East would spearhead the market attributed
to the rising prevalence of sleep apnea.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876
Get More Related
Report
Hair Transplant
Market @ https://www.marketresearchfuture.com/reports/hair-transplant-market-3409
Healthcare
Contract Manufacturing Market @ https://www.marketresearchfuture.com/reports/healthcare-contract-manufacturing-market-5637
Hazmat Suits
Market @ https://www.marketresearchfuture.com/reports/hazmat-suits-market-8226
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America